Europe EGFR Mutation Test Market was valued at USD 1.00 Billion in 2022 and is projected to reach USD 1.70 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030.
The EGFR Mutation Test Market in Europe has seen significant growth in recent years due to increasing awareness and demand for precision medicine, especially in the oncology sector. This test is vital for diagnosing lung cancer, specifically non-small cell lung cancer (NSCLC), by identifying mutations in the epidermal growth factor receptor (EGFR) gene. These mutations are crucial in determining the most effective targeted therapies, making the EGFR Mutation Test an essential tool in modern healthcare.
One of the primary drivers of this market is the rising incidence of lung cancer across Europe. According to recent statistics, lung cancer remains one of the deadliest cancers in the region, prompting healthcare professionals to seek more precise and individualized treatment options. The EGFR Mutation Test plays a crucial role in providing these options by helping doctors to understand which treatment regimens are likely to be most effective for each patient.
The market for EGFR mutation testing is being further propelled by advancements in molecular diagnostic technologies. With more efficient and cost-effective testing methods available, healthcare providers are increasingly adopting EGFR mutation tests. As a result, industries within the healthcare sector, including diagnostic laboratories and pharmaceutical companies, are increasingly relying on these tests to improve patient outcomes and guide treatment decisions.
From an industrial perspective, pharmaceutical companies are particularly interested in the EGFR Mutation Test Market. These companies are focused on developing and marketing targeted therapies, such as tyrosine kinase inhibitors, which are specifically designed to target and inhibit EGFR mutations in cancer cells. As a result, the demand for EGFR mutation testing is expected to remain strong, as it directly influences drug development and approval processes.
The requirement for EGFR mutation tests is not limited to just healthcare providers and pharmaceutical industries. Diagnostic laboratories, both independent and hospital-based, require access to high-quality, reliable EGFR mutation testing kits to meet growing demand. Additionally, many healthcare systems across Europe are now incorporating genetic testing into routine cancer screening, further driving the need for advanced testing methods.
As more healthcare institutions adopt EGFR mutation testing as a standard practice, the market continues to expand, with strong prospects for future growth. The integration of these tests into routine oncology care will be pivotal in the fight against cancer, offering patients more personalized and effective treatment options, ultimately improving survival rates across Europe.
Get an In-Depth Research Analysis of the Europe EGFR Mutation Test Market Size And Forecast [2025-2032]
Â
Abbott
Merck
Thermo Fisher Scientific
Illumina
BioMerieux
QIAGEN
Agilent Technologies
Hologic
Novartis
Roche
Genomic Health
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe EGFR Mutation Test Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe EGFR Mutation Test Market
Biopsy-based tests
Blood-based tests
Urine-based tests
Cancer Diagnostics
Personalized Medicine
Drug Resistance Monitoring
Prognostic Biomarkers
Hospitals
Diagnostic Laboratories
Research Institutions
Oncology Clinics
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Fluorescence In Situ Hybridization (FISH)
Immunohistochemistry (IHC)
Reagents & Kits
Instruments
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
For More Information or Query, Visit @ EGFR Mutation Test Market Research Analysis
1. Introduction of the Europe EGFR Mutation Test Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe EGFR Mutation Test Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe EGFR Mutation Test Market, By Type
6. Europe EGFR Mutation Test Market, By Application
7. Europe EGFR Mutation Test Market, By Geography
Europe
Germany
UK
France
8. Europe EGFR Mutation Test Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/